The ABLATE PAS demonstrates durable Afib freedom across 3 years.
Consistent with the ABLATE IDE Trial, these findings reinforce the long-term effectiveness and durability of surgical ablation in a real-world patient population. Learn more about the study:
- Healthcare Professionals
- Patients & Caregivers
- About AtriCure
- Canada, Central & South America
